Evidence map›Paper›PMID 37636079›Full record

ArticleiScience2023

Human fetal dermal fibroblast-myeloid cell diversity is characterized by dominance of pro-healing Annexin1-FPR1 signaling.

Rajneesh Srivastava, Kanhaiya Singh, Ahmed S Abouhashem, Manishekhar Kumar, Sedat Kacar, Sumit S Verma, Sujit K Mohanty, Mithun Sinha, Subhadip Ghatak, Yi Xuan and 1 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. RestoringFrontiers in cell and developmental biology · 2026
    Article
  3. Direct in vivo reprogramming to relieve tissue ischemia via induced vasculogenesis.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Rajneesh SrivastavaMcGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Kanhaiya SinghMcGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Ahmed S AbouhashemIndiana Center for Regenerative Medicine and Engineering, Indiana University Health Comprehensive Wound Center, Indiana University School of Medicine, Indianapolis, IN, USA.
Manishekhar KumarMcGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Sedat KacarIndiana Center for Regenerative Medicine and Engineering, Indiana University Health Comprehensive Wound Center, Indiana University School of Medicine, Indianapolis, IN, USA.
Sumit S VermaMcGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Sujit K MohantyMcGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Mithun SinhaIndiana Center for Regenerative Medicine and Engineering, Indiana University Health Comprehensive Wound Center, Indiana University School of Medicine, Indianapolis, IN, USA.
Subhadip GhatakMcGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Yi XuanMcGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Chandan K SenMcGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Indiana University School of MedicineMcGowan Institute for Regenerative Medicine · USUniversity of Pittsburgh · USIndiana University – Purdue University Indianapolis · US

Funding

Diabetic Foot Ulcer Biofilm Infection and RecurrenceR01DK125835 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GURTNER, GEOFFREY C, SEN, CHANDAN K · 2020 to 2024
$3.5M
Cell Specific Gene Editing to Close Diabetic WoundsR01DK135447 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Chandan K Sen · 2023 to 2026
$2.2M
Regulatory Mechanisms Addressing Diabetic VasculopathyR01DK136814 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Kanhaiya Singh · 2023 to 2026
$1.9M
Tissue reprogramming in diabetic wound healingR01DK128845 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROY, SASHWATI, SEN, CHANDAN K · 2021 to 2023
$1.5M
Nanofabricated Devices and Nanomedicine Approaches for Wound HealingK25GM143572 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XUAN, YI · 2021 to 2024
$624k
NIDDK NIH HHS R01 DK125835NIDDK NIH HHS R01 DK128845NIDDK NIH HHS R01 DK135447NIDDK NIH HHS R01 DK136814NIGMS NIH HHS K25 GM143572
6 · The paper itself

Abstract

Fetal skin achieves scarless wound repair. Dermal fibroblasts play a central role in extracellular matrix deposition and scarring outcomes. Both fetal and gingival wound repair share minimal scarring outcomes. We tested the hypothesis that compared to adult skin fibroblasts, human fetal skin fibroblast diversity is unique and partly overlaps with gingival skin fibroblasts. Human fetal skin (FS, n = 3), gingiva (HGG, n = 13), and mature skin (MS, n = 13) were compared at single-cell resolution. Dermal fibroblasts, the most abundant cluster, were examined to establish a connectome with other skin cells. Annexin1-FPR1 signaling pathway was dominant in both FS as well as HGG fibroblasts and related myeloid cells while scanty in MS fibroblasts. Myeloid-specific FPR1-ORF delivered in murine wound edge using tissue nanotransfection (TNT) technology significantly enhanced the quality of healing. Pseudotime analyses identified the co-existence of an HGG fibroblast subset with FPR1

Indexed as

Cell biologyImmunologyMolecular biologyTranscriptomics

Identifiers

PMID37636079
PMCPMC10450526
OpenAlexW4385478296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.